DC1s-CTL Cellular Therapy for Renal Cell Carcinoma

NCT02787915 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xuzhou Medical University